Statistics

Total Visits

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study17

Select a period of time:

Number of views in the range

Views
Low-dose metronomic oral cyclophosphamide plus prednisone for castration resistant prostate cancer (CRPC): A retrospective study12

Views

Views
November 20231
December 20231
January 20242
February 20241
March 20245
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Hong Kong5
 

Top cities views

Views
Central5
Boardman2
Ashburn2
Chicago1